199850-67-4

• 常用中文名：N-[(4'-溴[1,1'-联苯]-4-基)磺酰基]-L-缬氨酸
• 常用英文名：PD 166793
• CAS号：199850-67-4
• 分子式：C₁₇H₁₈BrNO₄S
• 分子量：412.29800
• 相关类别： 生物化工 氨基酸及其衍生物 缬氨酸类衍生物
• 发布时间：2019-01-02 22:02:03
• 更新时间：2026-08-28 10:53:52
• PD-166793 is a cell-permeable biphenylsulfonylvaline compound that acts as a potent inhibitor against MMP-2, -3, and -13 (IC50 = 47, 12, and 8 nM, respectively) and a weaker inhibitor against AMP deaminase (20% inhibition at 0.1 μM), MMP-1, -7, -9, and -14 (IC50 = 6.1, 7.2, 7.9, and 0.24 μM, respectively). Shown to offer therapeutic benefits in vivo in various animal models of heart failure and diabetes.

名称

• 中文名: (S)-2-(4’-溴联苯-4-磺酰胺)-3-甲基丁酸
• 英文名: (2S)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid
• 中文别名: (S)-2-(4'-溴-[1,1'-联苯]-4-基磺酰胺基)-3-甲基丁酸; (S)-2-(4'-溴联苯-4-磺酰胺)-3-甲基丁酸; (S)-2-(4'-溴-[1,1'-联苯]-4-基磺酰胺O)-3-甲基丁酸; PD 166793,广谱MMP抑制剂
• 英文别名: (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid; MMP-2/MMP-3 Inhibitor; (S)-2-(4'-bromobiphenyl-4-ylsulfonamido)-3-methylbutanoic acid; (2S)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-3-methylbutanoicaci; PD-166793-0000; MMP-2/MMP-3 Inhibitor III, PD166793; L-Valine, N-[(4'-bromo[1,1'-biphenyl]-4-yl)sulfonyl]; N-[(4'-Bromo[1,1'-biphenyl]-4-yl)sulfonyl]-L-valine; PD-166793, 10 mM in DMSO; PD 166793 //BP

物化性质

• 密度: 1.457g/cm3
• 沸点: 562.069ºC at 760 mmHg
• 熔点: 192-193℃
• 分子式: C₁₇H₁₈BrNO₄S
• 分子量: 412.29800
• 闪点: 293.729ºC
• 精确质量: 411.01400
• PSA: 91.85000
• LogP: 4.97530
• 蒸汽压: 0mmHg at 25°C
• 折射率: 1.597
• 储存条件: Desiccate at +4°C

合成路线

199850-87-8 ~68% 199850-67-4

文献：O'Brien, Patrick M.; Ortwine, Daniel F.; Pavlovsky, Alexander G.; Picard, Joseph A.; Sliskovic, Drago R.; Roth, Bruce D.; Dyer, Richard D.; Johnson, Linda L.; Man, Chiu Fai; Hallak, Hussein Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 156 - 166

92-66-0 ~% 199850-67-4

文献：O'Brien, Patrick M.; Ortwine, Daniel F.; Pavlovsky, Alexander G.; Picard, Joseph A.; Sliskovic, Drago R.; Roth, Bruce D.; Dyer, Richard D.; Johnson, Linda L.; Man, Chiu Fai; Hallak, Hussein Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 156 - 166

13610-11-2 ~% 199850-67-4

文献：O'Brien, Patrick M.; Ortwine, Daniel F.; Pavlovsky, Alexander G.; Picard, Joseph A.; Sliskovic, Drago R.; Roth, Bruce D.; Dyer, Richard D.; Johnson, Linda L.; Man, Chiu Fai; Hallak, Hussein Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 156 - 166

78079-08-0 ~% 199850-67-4

文献：O'Brien, Patrick M.; Ortwine, Daniel F.; Pavlovsky, Alexander G.; Picard, Joseph A.; Sliskovic, Drago R.; Roth, Bruce D.; Dyer, Richard D.; Johnson, Linda L.; Man, Chiu Fai; Hallak, Hussein Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 156 - 166

上下游产品

上游产品  3
92-66-0 13610-11-2 78079-08-0
下游产品  0